Introduction
Neuroendocrine tumours (NETs) arise in most organs of the body and are defined as epithelial neoplasms with prominent neuroendocrine differentiation [1] . This heterogeneous group of tumours are often classified by their site of origin, and also by their ability to store and secrete hormones leading to specific clinical syndromes [2] .
Functioning tumours are usually small and tend to present relatively early due to their associated clinical syndromes; therefore, they are often difficult to localize with conventional cross-sectional imaging. Nonfunctioning tumours, however, often present late with nonspecific symptoms, local mass effect or symptoms associated with distant metastatic spread. Although there have been significant therapeutic advances in medical treatment of these rare tumours, surgical resection remains the gold standard in achieving cure [3 ] .
The most optimal imaging technique in tumour localization is not only highly dependent upon the type and grade of NET, but also upon the local imaging techniques and expertise available at a specialist unit [4] .
Preoperative localization and staging of a primary NET is key in achieving the goal of surgical cure. Current guidelines emphasize the importance of functional imaging/ localization for NET evaluation [5 ,6] . Conventional cross-sectional imaging techniques have shown variable success in the detection of these, often inconspicuous tumours. The utility of venous sampling in the localization of such tumours has been well documented in the literature with excellent historical success. This paper will briefly review the specific current role of interventional venous sampling in the functional localization of select NETs, specifically in the diagnosis and management of Cushing's syndrome, hyperparathyroidism, pancreatic NETs (PNETs), hyperaldosteronism, phaeochromocytomas and androgen secreting ovarian tumours.
Cushing's syndrome
Endogenous Cushing's syndrome is a clinical state arising from prolonged and inappropriate exposure to glucocorticoids [7] . Pituitary corticotroph adenoma (Cushing's disease) accounts for 80-90% of ACTH-dependent causes, the other 10-20%, due to ectopic-ACTH Differentiation of pituitary dependent Cushing's disease from ectopic ACTH secretion is key; however, despite the availability of numerous noninvasive biochemical tests, none achieve 100% diagnostic accuracy. Transphenoidal surgery remains the treatment of choice in Cushing's disease; however, localization can be problematic in these patients. MRI with gadolinium enhancement is the initial imaging modality of choice in Cushing's disease, although sensitivity and specificity is poor, ranging from approximately 50-75% [9,10 ,11,12] . A recent retrospective analysis of diagnostic performance of MRI in adult and adolescent Cushing's disease demonstrated sensitivity of 75% in adults and 55% in the adolescent group [10 ] , and similar studies have shown poor concordance of pituitary imaging with surgical findings in the paediatric population [13 ] . Incidental pituitary lesions are seen in up to 10% of the general population, so detection of a pituitary lesion on MRI alone cannot be relied upon to establish a functional tumour [14, 15] . Conversely, a normal MRI does not exclude a pituitary corticotroph adenoma because these lesions are often small and inconspicuous [16] . Despite this, a consensus statement from 2003 suggested that typical clinical presentation and dynamic biochemical parameters in keeping with Cushing's syndrome and a focal (>6 mm) lesion on pituitary MRI should be considered sufficient evidence to make a diagnosis of Cushing's disease without the need for venous sampling [9] .
Bilateral inferior petrosal sinus sampling (BIPSS), originally described by Corrigan et al. and refined by others [17] [18] [19] is utilized as the functional localization technique of choice in those patients with negative or discordant biochemical and imaging studies. This technique utilizes the central measurement of ACTH produced by pituitary corticotroph tumour cells (native pituitary production of ACTH is suppressed by a state of hypercortisolaemia) compared with peripheral ACTH values and expressed as a ratio. Measurements are typically made before and after administration of CRH, as many corticotroph adenomas are susceptible to stimulation by CRH, which is exploited to increase the sensitivity of BIPSS. Optimal catheter placement, confirmed by demonstrating crossover flow into the contralateral petrosal sinus following contrast injection (Fig. 1 ) is vital to ensure diagnostic results and avoiding false negative outcomes. More recently, biochemical methods of assessing adequate venous sampling have been proposed by measuring other anterior pituitary hormone ratios. Concurrent prolactin measurements with central:peripheral hormone ratio close to 1.0 may suggest inadequate catheter placement/sampling and may lead to false-negative results. Moreover, recent studies have investigated the role of measuring other anterior pituitary hormones (prolactin, growth hormone) as surrogates in the localization of ACTH-dependent tumours, which are paradoxically increased following CRH stimulation [20] [21] [22] .
BIPSS has been shown to be both highly sensitive and specific (88-100 and 67-100%, respectively) in the localization of corticotroph secreting pituitary tumours. Its use is indicated in patients whose clinical, biochemical, or radiological studies are discordant [8, 9, 15] . Several recent studies have shown significant value of BIPSS in paediatric patients, in whom conventional MRI performs relatively poorly [10 ,13 ,23-25] . A recent study by Storr et al. [10 ] compared the diagnostic performance of MRI and BIPSS in adults and paediatric populations. They showed higher comparative detection sensitivity of BIPSS compared to MRI in both adults and paediatric groups (approximately 80%); however, inferior performance of MRI in the paediatric population (55%) compared with adults (73%).
Localising a corticotroph adenoma within the sella may be helpful in performing selective/partial trasnsphenoidal pituitary surgery with the prospect of preserving anterior pituitary function. This can be difficult with microadenomas particularly when pituitary MRI is negative or equivocal. Several studies have looked into the ability of BIPSS to lateralize tumours by the calculation of inferior petrosal sinus gradients from one side to another. Accuracy of BIPSS in localizing tumours is variable, ranging from 50-100% [7] . A side-to-side gradient of at least 1.4 before or after CRH stimulation indicates a lateralizing tumour and a gradient less than 1.4 indicates a midline lesion, with an accuracy of approximately 70% [26] . However, false-positive results can be attributed to asymmetric venous anatomy or suboptimal catheter positioning [27] . In patients without MRI evidence of tumour, some have advocated surgical hemihypophysectomy as a management strategy directed by raised ipsilateral ACTH levels during sampling, so long as patients have symmetrical venous anatomy, and a positive interpetrosal gradient [28] . Measurement of prolactin in lateralization of corticotroph adenomas have been studied with mixed results, and in general, not shown to be contributory [22] .
Although BIPSS is recognized as a sensitive and specific technique in the functional localization of corticotroph adenomas, several centres have described other methods of sampling, particularly in which expertise in BIPSS is not readily available. Jugular venous sampling (JVS) has been shown to be a useful, although less selective, method in the confirmation of Cushing's disease. Comparative studies looking at detection performance of BIPSS versus JVS have shown sensitivities of 94 and 82%, respectively [29, 30] .
Cavernous venous sampling is a highly selective and sensitive technique in the detection and lateralization of pituitary corticotroph secreting adenomas. However, most institutions (including the authors own) do not advocate its use due to the small (but significant) risks associated with cavernous venous sampling.
The role of venous sampling in the detection of ectopic (extrapituitary) ACTH-dependent tumours is less established. Case reports have described pulmonary arterial sampling in the detection of ACTH-producing pulmonary/bronchial tumours (small cell and carcinoid tumours); however, these techniques are performed ad hoc rather than from established protocols [31] .
Pancreatic neuroendocrine tumours
PNETs are rare neoplasms arising from pluripotent cells of the islet of Langerhans, and account for 1-2% of all pancreatic neoplasms [32] . PNETs are broadly divided into two clinical groups: functioning and nonfunctioning, the latter being more common (70-90%) [33] . Functional tumours are classified according to the hormones they secrete leading to specific clinical syndromes, although some produce more than one hormone [34] . An overview of the most common PNETs is shown in Table 1 .
PNETs may occur sporadically or more commonly (30-75%) as part of an inherited clinical syndrome [multiple endocrine neoplasia type 1 (MEN1), von Hippel-Lindau (vHL), neurofibromatosis type 1 and tuberous sclerosis]. Functioning PNETs are invariably small at presentation, making localization difficult. Insulinomas are the commonest functioning PNETs accounting for 50% of cases, are usually solitary (although multiple in MEN1) and measure less than 2 cm and less than 1 cm in 90 and 40% of cases, respectively [35, 36] . Gastrinomas are the second most common group of functioning PNETs, and unlike insulinomas, are more likely to be malignant, multiple, smaller and extrapancreatic. These functional tumours are often small and therefore particularly difficult to identify, especially in their early stages. Early localization with imaging is important to guide prompt, and often curative, management of these tumours.
Conventional imaging with computed tomography (CT) and MRI remain initial imaging modalities of choice allowing rapid, noninvasive assessment of the abdomen, including sites of potential metastatic spread [37] . Historically, reported performance of CT and MRI has been poor [4, 38] ; however, advances in imaging technology and techniques have improved CT and MRI sensitivity up to 94% [39] [40] [41] . MRI is superior to angiography and CT for detection of metastatic disease [40] [41] [42] . A recent study by Druce et al. [43 ] demonstrated detection sensitivities of insulinomas using CT and MRI in the region of 64 and 75%, respectively, with combined modality detection sensitivity of 80%.
Invasive techniques in PNET localization have demonstrated better results than established cross-sectional techniques. Endoscopic ultrasound (EUS) has become an integral part in the diagnosis of PNETs due to its high sensitivity for detecting, localizing and diagnosing PNETs [44] . Detection sensitivity has been reported in the range of 70-94% with specificity approaching 95% [45] [46] [47] [48] . EUS has the added advantage of being able to achieve histological diagnosis by fine needle aspiration and detection of tiny pancreatic lesions in the order of 2-3 mm [44] . However, EUS sensitivity is significantly lower in detection of lesions within the pancreatic tail and extrapancreatic locations, is highly operator dependent and is invasive. Intraoperative ultrasound combined with palpation demonstrates high sensitivity (range 74-96%) [49] [50] [51] , although arguably this falls outside the realms of preoperative assessment.
Functional localization with somatostatin receptor scintigraphy (SRS) has earned its central place in diagnostic work-up of PNETs [5 ] The use of SRS is two-fold. First, it is used in the diagnosis and localization of primary PNETs and to assess possible distant metastases, particularly important when curative surgery is contemplated [52] . Second, the role of SRS has evolved in determining therapeutic approaches using peptide receptor radionuclide therapy (PRRT) in the targeted treatment of advanced disease [6, 53] . SRS of functional and nonfunctional PNETs has been shown to be superior to CT, MRI, angiography and EUS [54, 55] . There has been significant advancement in the utility of PET-CT in PNETs, specifically interest in various peptides such as 68Ga-DOTA in the localization and staging of PNETs [53, [56] [57] [58] . These cutting edge molecular imaging methods have outperformed conventional imaging techniques, but their use in specific clinical settings is limited by several factors, including availability, expertise, finances, laws and regulations. More validation studies are required before novel PET tracers are incorporated into existing diagnostic and treatment algorithms.
Selective arterial stimulation with calcium and simultaneous venous sampling has been widely described as being highly sensitive and specific in the localization and treatment planning of PNETs. This technique is specifically used in the diagnosis and localization of insulinomas and gastrinomas, the commonest of the functioning PNETs.
Specific indications for use of arterial stimulation and venous sampling (ASVS) in the diagnostic work-up of PNETs include failure to localize functional PNET with other imaging modalities; localization of functional tumour(s) in the presence of multiple dormant pancreatic lesions particularly associated with MEN1; allowing lateralization of tumour within the pancreas, in relation to the superior mesenteric artery, therefore allowing surgical approach to be planned (i.e. laparoscopic, enucleation, distal pancreatectomy or pancreatoduodenectomy) [59] .
Localization of insulinomas (and more recently gastrinomas) is based upon the injection of hyperosmolar calcium into selective arteries supplying different anatomical portions of the pancreas. This leads to degranulation of tumour cells, releasing insulin into the portal vein and from there into the hepatic venous system where it is detected [60] . Therefore, both arterial and venous catheters are required to be in position simultaneously (usually via ipsilateral femoral vessel punctures); a venous catheter within a hepatic vein sampling insulin or gastrin and an arterial catheter injecting secretagogue (hyperosmolar calcium) into selective arteries. This correlation of the site of injection with secondary rise in insulin or gastrin from the hepatic veins, allows diagnosis and lateralization of tumour within the pancreas. In addition, digital subtraction angiography following selective catheterization allows added anatomical localization (Fig. 2) ; however, detection sensitivity for this technique is variable ranging from 40-94% [60] [61] [62] [63] .
The diagnostic performance of ASVS has been widely reported, although data is mainly limited to small powered series and case reports because of the rarity of these tumours [60] . The majority of studies have looked at the role of ASVS in detection of insulinomas, with fewer looking at its role in gastrinomas. The largest study of insulinomas localization using ASVS, by The National Institute of Health (NIH) in 2009 recruited 76 patients who underwent standard biochemical, cross-sectional imaging and ASVS protocols. They showed superior diagnostic performance of ASVS with sensitivity of 89% compared with CT, magnetic resonance and ultrasound sensitivity of 28, 35 and 14%, respectively [64] .
An earlier study (n ¼ 27) by Wiesli et al. [65] also demonstrated similar diagnostic performance of ASVS with sensitivity of 96 versus 59% for CT/MRI. Other groups have also shown similar results. ASVS has also shown to be of significant value in localization of tumours that were inconspicuous on ultrasound, CT, MRI, EUS and intraoperative bimanual palpation [64, 66] . However, the study by Druce et al. [43 ] showed a combined CT/MRI insulinoma localization sensitivity of 80%, superior to that of ASVS at 64%. The authors highlight the merit of reserving this invasive imaging modality in those cases in which noninvasive measures are contentious; however, others advocate its use in all patients prior to surgical intervention [67] . A recent case report by Katayama et al. [68] describes detection of a small insulinoma that was inconspicuous in conventional dynamic CT, MRI and digital subtraction angiography. ASVS localized the lesion to the head of the pancreas. The patient then underwent super selective CT angiography via a catheter placed in the gastroduodenal artery, which demonstrated a small hypervascular insulinoma.
The role of angiography and ASVS is less clear-cut in the localization of gastrinomas. SRS and EUS will detect up to 90% of gastrinomas and therefore, ASVS could be reserved to cases in which conventional imaging has failed [60] . Detection sensitivity of gastrinomas with ASVS has been reported in the range of 77-100%, although cases series have been small [62, [69] [70] [71] .
Parathyroid tumours
Primary hyperparathyroidism is most commonly associated with sporadic parathyroid adenomas (approximately 85%) [72] . Small, but significant proportions are associated with familial hyperparathyroid syndromes such as MEN1, MEN2a, hyperparathyroidism-jaw tumour syndrome and familial isolated hyperparathyroidism [73] . Approximately 88-97% of MEN1 gene carriers will develop hyperparathyroidism [74, 75] . Surgery offers definitive cure in up to 95% of patients with low complication rates. Historically, bilateral surgical exploration had been considered to be the 'gold-standard'; however, highly specific localization techniques with high frequency ultrasound, CT, MRI and most importantly, Technetium (99mTc) labelled methoxyisobutylisonitrile (MIBI) have increased the trend towards minimally invasive parathyroid surgery.
The role of venous sampling in the localization of functional parathyroid tumours has been mainly confined to those patients requiring reoperation for recurrent or relapsed hyperparathyroidism.
Ultrasound and MIBI [particularly with subtraction and single photon emission computed tomography (SPECT)] have been shown to be highly sensitive (approaching 95%) in the localization of parathyroid tumours in the setting of single gland disease. However, localization in the context of multigland disease, reoperative cases and in those with concomitant thyroid nodular disease has shown less favourable results, with sensitivities of these noninvasive techniques as low as 25-62% [76 ] . CT and MRI have a limited role mainly in the localization of ectopic retrosternal parathyroid adenoma.
Presurgical localization with selective venous sampling (SVS) is generally not required in uncomplicated hyperparathyroidism due to the high sensitivity of MIBI and ultrasound. SVS, however, has been shown to be a valuable utility in patients who have had previous neck surgery to define the extent of distorted anatomy, patients known or suspected to have a familial hyperparathyroid syndrome, cases with nonconcordant or misleading functional and/or anatomical imaging and patients with evidence of multigland involvement or ectopic disease with MIBI [59, 73] .
Several studies have shown the superior diagnostic performance of selective parathyroid venous sampling in the select subgroup of patients mentioned above, when compared with conventional noninvasive imaging techniques. The single largest study by the NIH group (n ¼ 222) reported on the performance of venous sampling in reoperative groups [72] . They showed superior diagnostic performance of venous sampling with a true-positive rate of 76% compared with 67 and 48% for MIBI and ultrasound, respectively. Other investigators have also shown superior results of SVS with high sensitivity for localization [73, [77] [78] [79] .
A recent study by Witteveen et al. [76 ] assessed the role of SVS in the management of patients with persistent or recurrent hyperparathyroidism. They accurately located 71% of pathological glands missed by MIBI-SPECT. MIBI-SPECT alone detected 30% of lesions in this cohort of patients; however, SVS and MIBI-SPECT combined, achieved detection sensitivity of 100%.
The role of less SVS in the way of JVS (preoperative, intraoperative and even 'office-based') has shown favourable results, although their role in complicated hyperparathyroidism and ectopic parathyroid disease is limited [80] . Selective parathyroid venous sampling remains the procedure of choice in this setting, although financial constraints and availability of this highly skilled procedure limits this preoperative technique to specialist units.
Adrenal neuroendocrine tumours
Primary hyperaldosteronism is the commonest endocrine cause of hypertension with the choice of treatment dependent upon the lateralization of aldosterone secretion. Significant improvement or even cure of hypertension may be achieved following adrenalectomy in patients with unilateral aldosterone overproduction.
Aldosterone producing adenomas and bilateral adrenal hyperplasia are the commonest causes of hyperaldosteronism. Rare causes include: unilateral adrenal hyperplasia, adrenocortical carcinoma and familial hyperaldosteronism [81] . Presurgical localization is key in achieving a curative surgical outcome.
Conventional cross-sectional imaging with CT and MRI can be highly sensitive in the detection of adrenal adenomas, with sensitivities as high as 90%. However, a small but significant proportion of the normal population will have nonfunctioning adrenal incidentalomas. In addition, recent studies have highlighted the pitfalls of noninvasive techniques in the diagnosis and lateralization of these tumours [82] .
Adrenal vein sampling (AVS) is considered the 'goldstandard' in the preoperative localization of aldosteronesecreting adenomas in patients with primary hyperaldosteronism, with high-accuracy rates ranging from 92-100% [83] [84] [85] [86] . AVS technique, like other venous sampling techniques requires expertise in achieving high-diagnostic performance. Optimal catheter placement may be confirmed by adrenal venography and by assessing cortisol or catecholamine levels obtained at each site, with high levels associated with consistent AVS results [87, 88] . However, there remains a lack of standardization in the use of pre-ACTH versus post-ACTH stimulation values in achieving catheter diagnosis [82] .
A prospective study by Young et al. [81] looked at the value of AVS in those with equivocal CT findings. They showed that using CT findings alone, 21.7% of patients would have been incorrectly excluded as candidates for adrenalectomy and 24.7% of patients would have had an unnecessary or inappropriate adrenalectomy. A more recent study conducted by Mathur et al. [82] reinforced these findings by showing that of a group of 114 patients, 57 patients (50%) would have had inappropriate management based on CT findings alone.
Therefore, most recent literature advocates the use of preoperative localization with AVS in all patients in whom surgical intervention is contemplated [89] .
Phaeochromocytomas and paragangliomas
Conventional and novel imaging techniques form the cornerstone of imaging in the diagnosis of phaeochromocytomas and paragangliomas. Detection with CT, MRI, metaiodobenzylguanidine (MIBG) and PET has allowed sensitivity and specificity of these techniques to approach 100%. The role of venous sampling in localization of these tumours is limited.
Venous sampling has been used in the localization of occult tumours when other imaging modalities have been noncontributory and detection of bilateral disease in the context of associated familial syndromes (MEN-2, SDHD and vHL) [90] [91] [92] . A recent case report demonstrates the value of venous sampling in select cases, particularly those associated with genetic syndromes, in which there is an impact on subsequent patient management [93] .
However, of note, a recent study by Freel et al. [94 ] sought to establish the reference range of catecholamine secretion from adrenal veins in those without phaeochromocytomas or paragangliomas. They found significant normal variation in catecholamine concentrations, and in some cases, an 83-fold difference between right and left adrenal veins, therefore concluding venous sampling should not be used in the diagnostic work-up of these patients.
Ovarian functional tumours
Hyperandrogenism is common in women, most commonly attributable to a nontumourous cause like polycystic ovarian syndrome. However, one must consider and exclude the presence of androgenic secreting tumours. Differentiation of androgen secreting tumour from nontumourous cause may be achieved with the use of low-dose dexamathasone-suppression test with sensitivity and specificity of 100 and 88%, respectively [59] . A peripheral testosterone value of at least 4.51 nmol/l (130 ng/dl) increases the probability of an androgensecreting tumour in the appropriate clinical context (sensitivity 94% and specificity of 78%) [95] .
Initial imaging with adrenal CT/MRI and ovarian ultrasound should be performed to detect an overt androgensecreting tumour. CT/MRI and PET have been shown to be highly sensitive and specific in identifying adrenal tumours with sensitivities ranging from 70-97% [96] . Ovarian tumours on the contrary, may often be small (<2 cm) and inconspicuous using diagnostic and surgical techniques.
Ovarian venous sampling (together with adrenal venous sampling) has shown success in tumour localization (and exclusion) in cases in which standard imaging has failed. This technique requires selective catheterization of both adrenal and ovarian veins, a success rate reported to be in the region of 27-45% [97, 98] . This low success rate can be attributed to variation in venous anatomy, size of vein and presence of competent venous valves [59] . Furthermore, no consensus exists with regards to testosterone gradients required in localising androgen tumours. A review and analysis of the existing literature by Levens et al. [95] suggested that SVS could localize the side of tumour with an overall sensitivity of 66%.
Conclusion
NETs represent a clinically unique group of lesions that pose real challenges in their diagnostic work-up, irrespective of their site of origin. Localization of these tumours is key in allowing successful management strategy. This review highlights the key role of venous sampling in the localization of these tumours, its use invariably complimentary to the barrage of continually evolving imaging modalities already in place. Of note, venous sampling offers unique functional, and in selected cases, anatomical localization of tumours. One must not forget the invasive nature of these studies; however, its superior diagnostic and localization properties cannot be ignored.
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